AstraZeneca is set to invest $26.5 million to establish a new diabetes drug production line at its Taizhou base in China.
ONGLYZA, an investigational drug under joint development by Bristol-Myers Squibb and AstraZeneca for the treatment of type 2 diabetes, was
AstraZeneca combo diabetes drug Qtrilmet approved in Europe.
AstraZeneca's diabetes drug Farxiga (dapagliflozin) failed to reach endpoints in a Phase III study as a potential treatment for hospitalized
Diabetes is a core therapeutic area for AstraZeneca and a key Medicines Unit, AstraZeneca. Contact for Inquiries . Corporate
Januvia, a diabetes drug from Merck: $113.00, a 79% discount. Farxiga, AstraZeneca's diabetes drug: $178.50, a 68% discount. Entresto, a
Medications that prevent blood clots and help with diabetes are among the first 10 drugs AstraZeneca, a drug manufacturer based in the
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating
Diabetes, Type 2, Heart Failure, Chronic Kidney Disease. Supplied by AstraZeneca. Drug Application for the treatment of type 2 diabetes
Comments